A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I

Clinical trial NCT06926621 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06926621
Sponsor: Vertex Pharmaceuticals Incorporated
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Myotonic Dystrophy Type 1 (DM1)

Start date: 2025-04-28
Primary completion: 2029-01-30
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.